TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06405087 updates: 1. completion date: 2032-01-26 → 2030-08-12 2. primary completion date: 2032-01-26 → 2030-08-12
Clinical trial NCT06405087 updates: 1. completion date: 2032-01-26 → 2030-08-12 2. primary completion date: 2032-01-26 → 2030-08-12
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical